Investing.com - Takeda Pharma ADR reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Takeda Pharma ADR announced earnings per share of $0.5361 on revenue of $7.96B. Analysts polled by Investing.com anticipated EPS of $0.2085 on revenue of $8.01B.
Takeda Pharma ADR shares are up 27% from the beginning of the year, still down 14.64% from its 52 week high of $20.42 set on February 7, 2020. They are outperforming the Nasdaq which is up 5.6% from the start of the year.
Takeda Pharma ADR shares gained 0.69% in pre-market trade following the report.
Takeda Pharma ADR follows other major sector earnings this month
Takeda Pharma ADR's report follows an earnings beat by Orsted ADR on Wednesday, who reported EPS of $0.2649 on revenue of $2.51B, compared to forecasts EPS of $0.141 on revenue of $2.65B.
Nintendo ADR had beat expectations on Monday with fourth quarter EPS of $1.63 on revenue of $6.04B, compared to forecast for EPS of $1.31 on revenue of $5.6B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar